Skip to content

Medical-device intelligence

QMN: Covid-19 Multi-Analyte Antigen Device

FDA product code QMN: Covid-19 Multi-Analyte Antigen Device. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QMN
FDA device name
Covid-19 Multi-Analyte Antigen Device
Device class
N
Regulation number
Not provided
Medical specialty
Unknown
Review panel
MI

FDA definition

A COVID-19 Multi-Analyte Antigen Device is a test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and common respiratory microorganisms in human respiratory and/or acceptable clinical specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Results should not be interpreted in the context of clinical observations, patient history, and/or epidemiological information, patient history, and/or epidemiological information.
Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 7 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Sep 30, 2020 to Jan 3, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QMN · Covid-19 Multi-Analyte Antigen Device07

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid pr…Z-1086-2024 · QMNQuidel CorporationRecallFeb 14, 2024FDA classification date
INDICAID COVID-19 Rapid Antigen At-Home Test, REF: P0040Z-0738-2024 · QMNPHASE SCIENTIFIC INTERNATIONAL LIMITEDRecallJan 17, 2024FDA classification date
BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, 30 Single Use Test Devices- Intended for the in vitro, simultaneous qualitative de…Z-1682-2023 · QMNBecton Dickinson & Co.RecallJun 2, 2023FDA classification date
Status COVID-19/Flu Rapid Immunoassay for Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenzas Type A, and Type B Antigens Sim…Z-2410-2021 · QMNVersea Diagnostics LLCRecallSep 3, 2021FDA record creation date
ACCEL ELISA COVID-19 for the detection of total antibodies to SARS-CoV-2 Catalog AE301U Kit lots: PXCOV073020, PXCOV081220 Expiration dates: Jan…Z-0510-2021 · QMNVEO DIAGNOSTICS, LLCRecallDec 1, 2020FDA record creation date
VITROS Immunodiagnostic Products-SARS-CoV-2 IgG Calibrator - Product Usage: In-Vitro Diagnostic (EUA) an aid in identifying individuals with an a…Z-0450-2021 · QMNOrtho Clinical Diagnostics IncRecallNov 13, 2020FDA record creation date
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Control - Product Usage: For use in monitoring the performance of the VITROS Immunodiagnosti…Z-0451-2021 · QMNOrtho Clinical Diagnostics IncRecallNov 13, 2020FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗